U.S. Markets closed

DermTech, Inc. (DMTK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
34.44-0.26 (-0.75%)
At close: 4:00PM EDT
34.44 0.00 (0.00%)
After hours: 05:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close34.70
Open34.67
Bid34.31 x 900
Ask34.75 x 1100
Day's Range34.15 - 35.60
52 Week Range9.85 - 84.49
Volume280,336
Avg. Volume625,548
Market Cap996.649M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out

    DermTech's innovative skin treatment is making it easier and cheaper to test for skin cancer, causing the business to grow. Fast.

  • Benzinga

    Chief Financial Officer Of Dermtech Makes $154.75 Thousand Sale

    Kevin Sun, Chief Financial Officer at Dermtech (NASDAQ:DMTK), made a large insider sell on September 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Sun sold 4,276 shares of Dermtech at a price of $36.19 per share. The total transaction amounted to $154,748. Sun still owns a total of 150,561 of Dermtech worth, $5,100,253. Dermtech shares are trading down 4.12% at $33.88 at the time of this writing on Monda

  • Motley Fool

    Should Investors Be Concerned About DermTech?

    DermTech (NASDAQ: DMTK) stock skyrocketed earlier this year. In this Motley Fool Live video recorded on Sept. 1, Motley Fool contributors Keith Speights and Brian Orelli address a viewer's question about whether there's reason to be concerned about DermTech. Keith Speights: Very quickly, Brian, let's hit one question before we end our segment.